BioCorRx Inc. (0001443863) recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating significant insider activity within the company. Form 4 is a document required to be filed with the SEC whenever there is a material change in the holdings of company insiders. This could include the buying or selling of company stock by directors, officers, or any beneficial owners of more than 10% of the company’s stock.
BioCorRx Inc. is a healthcare company that specializes in addiction treatment solutions. They are known for their innovative approaches to combating substance abuse, including their flagship program, the BioCorRx Recovery Program. This program utilizes a medication-assisted treatment to help individuals overcome addiction to alcohol and opioids. To learn more about BioCorRx Inc., visit their website at https://www.biocorrx.com.
Overall, the Form 4 filing by BioCorRx Inc. signifies important insider transactions within the company. Investors and stakeholders may want to keep an eye on these filings as they can provide valuable insights into the company’s financial health and potential future performance.
Read More:
BioCorRx Inc. (0001443863) Files SEC Form 4: Details Inside
Leave a Reply